TGFB1 and breast cancer: Another study found that TGF-β-induced EMT in a breast cancer cell model alters the response to EGF, leading to increased invasiveness and metastatic potential, which is characterized by changes in cell morphology, EGFR activation, and dependency on FAK [110].